SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

The Aircoin memecoin was born from a viral Twitter post from March, 2014 which proclaimed the following:   Evolution: 1. Aircoin 2. Fartcoin 3. Artcoin  Aircoin was launched in August, 2025 and CTO'd twice, with the second CTO team bringing vast experience and expertise to the project. The team includes industry veterans and visual arts professionals.  Aircoin is destined for greatness as a premier memecoin on the BONK.fun platform.

aircoin

AIRCOIN CRYPTO is trending with immense community enthusiasm following the launch of its "Airlock" feature, an innovative community-owned supply control mechanism on Solana. Users are actively locking over 30% of the token supply, driving conversations about making long-term holding a cornerstone for this memecoin.

Memecoin on Injective taken over by the community.

Nonja

Nonja is trending as a high-leverage meme on the Injective ecosystem, driven by community excitement around Injective's foundational strength and expanding infrastructure. Holders are rallying behind its robust liquidity and active community, anticipating substantial growth as a leading meme within the Injective ecosystem.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is trending due to securing an $816 million contract with the U.S. Space Development Agency to build missile defense satellites, marking its largest award to date. This significant deal is generating community excitement around the company's evolution into a diversified, end-to-end space solutions provider, positioning it for substantial long-term growth within the burgeoning space sector.

Root, Inc. is a technology insurance company, which engages in the provision of insurance services. It offers mobile telematics and technology platforms to segment individual risk based on complex behavioral data and customer experience to make pricing decisions and grow businesses. It provides insurance products and services in the United States. The company was founded by Alexander E. Timm and Daniel Manges in February 2015 and is headquartered in Columbus, OH.

Root Inc - Ordinary Shares - Class A

Root Inc

Root Inc. is heavily discussed following its recent earnings report, where management pointed to accelerating customer growth and a bullish outlook for 2026 driven by new pricing algorithms and channel expansion. Despite these operational improvements and arguments from bulls about deep undervaluation compared to peers, the stock has seen significant volatility and price declines, leading many to question market manipulation or management's ability to translate operational strength into shareholder value, with some deeming it "dead money" until a stronger catalyst.

Injective is an interoperable Layer 1 blockchain designed for DeFi applications. It provides developers with on-chain financial infrastructure modules to build dApps such as decentralized exchanges, prediction markets, and lending protocols. Its decentralized cross-chain bridging infrastructure offers compatibility with most blockchains, including EVM chains like Ethereum and non-EVM chains like Solana.

Injective

Injective is currently trending due to its pivotal role in bridging traditional finance with DeFi, driven by key developments such as the launch of its native EVM mainnet, significant institutional investments, and expansion into real-world asset derivatives. The community is actively discussing its strong deflationary tokenomics and strategic focus on AI and institutional on-chain adoption, viewing its ecosystem's meme coins as high-leverage plays.

Valero Energy Corp. engages in the manufacture and marketing of transportation fuels and other petrochemical products. It operates through the following business segments: Refining, Ethanol and Renewable Diesel. The Refining segment consists of refining operations, associated marketing activities, and logistics assets that support its refining operations. The Ethanol segment includes its ethanol operations, associated marketing activities, and logistics assets that support its ethanol operations. The Renewable Diesel covers the operations of Diamond Green Diesel Holdings LLC. The company was founded in 1980 and is headquartered in San Antonio, TX.

Valero Energy Corp.

Valero Energy is trending amidst heightened geopolitical tensions impacting global oil supply and refining capacity, fueling investor debates over crack spreads and sector profitability. Community discussion centers on Valero's strategic position in renewable fuels and robust capital returns, with diverse opinions on whether the stock presents a timely opportunity or faces significant headwinds, driving active technical trading.

Blue Foundry Bancorp operates as a bank holding company for Blue Foundry Bank, a savings bank that offers various banking products and services for individuals and businesses. It offers deposits and loans, such as one-to-four family residential property, home equity, commercial real estate, multi-family, construction, commercial and industrial, and other consumer loans, as well as home equity lines of credit. It operates branches in Bergen, Morris, Essex, and Passaic Counties. The company was founded in 1939 and is headquartered in Rutherford, NJ.

Blue Foundry Bancorp

Blue Foundry Bancorp (BLFY) is trending following the announcement of its all-stock merger with Fulton Financial, which is fueling significant upward price movement. The community is actively discussing the strategic implications of this acquisition, with considerable attention on call options as traders speculate on future growth.

Standard Lithium Ltd. engages in the testing and proving of the commercial viability of lithium extraction. Its projects include Arkansas Lithium, Lithium Brine Processing, and California Lithium. The company was founded by Alvaro Anthony on August 14, 1998 and is headquartered in Vancouver, Canada.

Standard Lithium Ltd

Standard Lithium (SLI) is gaining significant attention following robust U.S. government backing for its domestic lithium projects, including grants and strategic "fast-track" designations for developing the critical Smackover Formation. The community is intensely discussing the company's proprietary Direct Lithium Extraction technology and its role in establishing a secure national supply chain for essential battery minerals. This widespread optimism for its long-term potential persists despite broader sector volatility and recent equity financing efforts.

Mobileye Global, Inc. engages in the business of developing and deploying driver assistance systems and autonomous driving technologies and solutions. It operates under the Mobileye and Other segments. The company was founded by Amnon Shashua and Ziv Aviram in 1999 and is headquartered in Jerusalem, Israel.

Mobileye Global Inc - Ordinary Shares - Class A

MOBILEYE GLOBAL INC

Mobileye is actively discussed as its shares have trended downwards, puzzling many investors after the company recently reported stronger-than-expected Q2 earnings and raised its full-year guidance. This perplexing price action is largely attributed to continued selling pressure from Intel's partial stake divestment, overshadowing Mobileye's strong cash position, market leadership in ADAS, and strategic collaborations like its partnership with Innoviz for LiDAR in upcoming autonomous vehicle programs.

EyePoint Plc is a biopharmaceutical company, which engages in the development and commercialization of therapeutics that treat eye disorders. It offers FDA-approved sustained-release treatments in ophthalmology under the DEXYCU, ILUVIEN, Verisome, Retisert, and Durasert brands. The company was founded in 1987 and is headquartered in Watertown, MA.

EyePoint Inc.

EyePoint Pharmaceuticals Inc

EyePoint Pharmaceuticals is gaining significant attention due to strong 6-month Phase 2 results for its DURAVYU therapy in diabetic macular edema and accelerated enrollment in pivotal wet AMD trials. The community views DURAVYU as a potential first-to-market, best-in-class sustained-delivery treatment in two major retinal disease markets, fueling bullish sentiment and several analyst price target increases.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$PR So serious question here, probably been asked and answered: 
What&#39;s the consensus on this Q1 announced one-time variable divi? Price per share prediction, payout date, etc. 
I&#39;ve been focused on $12 to fold the teepee here, curious what most are expecting moving forward over the next 45 days and into Q2 payout. 
$1+/-  a share is tough to leave on the table, but it she&#39;s barcoding at $9.95 the next six months. It&#39;s been a long three years.

Zano

Newbee20

StockTwits Web

Permian Resources Corp - Ordinary Shares - Class A

 So serious question here, probably been asked and answered: 
What's the consensus on this Q1 announced one-time variable divi? Price per share prediction, payout date, etc. 
I've been focused on $12 to fold the teepee here, curious what most are expecting moving forward over the next 45 days and into Q2 payout. 
$1+/-  a share is tough to leave on the table, but it she's barcoding at $9.95 the next six months. It's been a long three years.

Frank Legan

@fullkurl UGH.  I&#39;m ready to sell at least 50% today and take my chances.  I just feel like there has to be a retrace of some sort.  @NotOfTheBody @axelf0ley thoughts?

Bilar

 UGH.  I'm ready to sell at least 50% today and take my chances.  I just feel like there has to be a retrace of some sort.  

@yimmys85 @NotOfTheBody @axelf0ley completely agreed, Jim.  But I&#39;ve told myself 12 or bust.

 completely agreed, Jim.  But I've told myself 12 or bust.

@fullkurl I&#39;m a big fan of small moves rather than selling half or 100%. I advocate small moves when buying too. I am trimming today but selling more like 20% or so of my current position in PR. Yes, it may correct a buck or more in the coming days/weeks, but I think there is more upside ahead, not just six months or a year from now but in the coming weeks and months. I think PR has proved itself. I see $14 or so as achievable in the next six months. That&#39;s my take.

 I'm a big fan of small moves rather than selling half or 100%. I advocate small moves when buying too. I am trimming today but selling more like 20% or so of my current position in PR. Yes, it may correct a buck or more in the coming days/weeks, but I think there is more upside ahead, not just six months or a year from now but in the coming weeks and months. I think PR has proved itself. I see $14 or so as achievable in the next six months. That's my take.

Angus Young

@fullkurl the math would be $1B FCF/4 Quarters x 50%. All that divided by outstanding shares.

Assumptions being that all 50% of the FCF goes towards the variable dividend and zero towards share buybacks which I think is a good assumption

matteo

StockTwits for iOS

 the math would be $1B FCF/4 Quarters x 50%. All that divided by outstanding shares.

Assumptions being that all 50% of the FCF goes towards the variable dividend and zero towards share buybacks which I think is a good assumption

Don Juan

@TXpureplayer Thank you, TX.  If I have this right at 558m OS the mental ju-jitsu tells me that&#39;s about .95 a share. +/-....  
Purely anecdotal, but I agree on the BBs, suspect that scenario is a no-go.

 Thank you, TX.  If I have this right at 558m OS the mental ju-jitsu tells me that's about .95 a share. +/-....  
Purely anecdotal, but I agree on the BBs, suspect that scenario is a no-go.

@fullkurl yep, so most likely $0.20-0.25 of variable dividend per qtr assuming FCF is equally distributed throughout the year which is unlikely

 yep, so most likely $0.20-0.25 of variable dividend per qtr assuming FCF is equally distributed throughout the year which is unlikely